Matthew Stubbs
2Patents
0h-index
4Co-inventors
21Inventor score
Filing activity: Nov 20, 2020 → Jun 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11738026B2 | Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor | Human Necessities | 0 | Active |
| US11833155B2 | Combination therapy for treatment of myeloproliferative neoplasms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.